spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search    

The fully linked HTML version of this article has now been published.
JCS ePress online publication date 14 Nov 2006
doi: 10.1242/jcs.03281


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.03281v1
119/23/4994    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeon, E. S.
Right arrow Articles by Kim, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeon, E. S.
Right arrow Articles by Kim, J. H.

Research Article

Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-{beta}-dependent mechanism


Eun Su Jeon, Hyun Jung Moon, Mi Jeong Lee, Hae Young Song, Young Mi Kim, Yong Chan Bae, Jin Sup Jung, and Jae Ho Kim*
* Author for correspondence (e-mail: jhkimst{at}pusan.ac.kr)

Mesenchymal stem cells (MSCs) can differentiate into diverse cell types including adipogenic, osteogenic, chondrogenic and myogenic lineages. In the present study, we demonstrated for the first time that sphingosylphosphorylcholine (SPC) induces differentiation of human adipose-tissue-derived mesenchymal stem cells (hATSCs) to smooth-muscle-like cell types. SPC increased the expression levels of several smooth-muscle-specific genes, such as those for {alpha}-smooth-muscle actin ({alpha}-SMA), h1-calponin and SM22{alpha}, as effectively as transforming growth factor {beta} (TGF-{beta}1) and TGF-{beta}3. SPC elicited delayed phosphorylation of Smad2 after 24 hours exposure, in contrast to rapid phosphorylation of Smad2 induced by TGF-{beta} treatment for 10 minutes. Pretreatment of the cells with pertussis toxin or U0126, an MEK inhibitor, markedly attenuated the SPC-induced expression of {alpha}-SMA and delayed phosphorylation of Smad2, suggesting that the Gi/o-ERK pathway is involved in the increased expression of {alpha}-SMA through induction of delayed Smad2 activation. In addition, SPC increased secretion of TGF-{beta}1 through an ERK-dependent pathway, and the SPC-induced expression of {alpha}-SMA and delayed phosphorylation of Smad2 were blocked by SB-431542, a TGF-{beta} type I receptor kinase inhibitor, or anti-TGF-{beta}1 neutralizing antibody. Silencing of Smad2 expression with small interfering RNA (siRNA) abrogated the SPC-induced expression of {alpha}-SMA. These results suggest that SPC-stimulated secretion of TGF-{beta}1 plays a crucial role in SPC-induced smooth muscle cell (SMC) differentiation through a Smad2-dependent pathway. Both SPC and TGF-{beta} increased the expression levels of serum-response factor (SRF) and myocardin, transcription factors involved in smooth muscle differentiation. siRNA-mediated depletion of SRF or myocardin abolished the {alpha}-SMA expression induced by SPC or TGF-{beta}. These results suggest that SPC induces differentiation of hATSCs to smooth-muscle-like cell types through Gi/o-ERK-dependent autocrine secretion of TGF-{beta}, which activates a Smad2-SRF/myocardin-dependent pathway.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
K. Vaahtomeri, E. Ventela, K. Laajanen, P. Katajisto, P.-J. Wipff, B. Hinz, T. Vallenius, M. Tiainen, and T. P. Makela
Lkb1 is required for TGF{beta}-mediated myofibroblast differentiation
J. Cell Sci., November 1, 2008; 121(21): 3531 - 3540.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. E. Westerweel and M. C. Verhaar
Directing Myogenic Mesenchymal Stem Cell Differentiation
Circ. Res., September 12, 2008; 103(6): 560 - 561.
[Full Text] [PDF]


Home page
Circ. Res.Home page
E. S. Jeon, W. S. Park, M. J. Lee, Y. M. Kim, J. Han, and J. H. Kim
A Rho Kinase/Myocardin-Related Transcription Factor-A-Dependent Mechanism Underlies the Sphingosylphosphorylcholine-Induced Differentiation of Mesenchymal Stem Cells Into Contractile Smooth Muscle Cells
Circ. Res., September 12, 2008; 103(6): 635 - 642.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. S. Jeon, H. J. Moon, M. J. Lee, H. Y. Song, Y. M. Kim, M. Cho, D.-S. Suh, M.-S. Yoon, C. L. Chang, J. S. Jung, et al.
Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells
Stem Cells, March 1, 2008; 26(3): 789 - 797.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. Gimble, A. J. Katz, and B. A. Bunnell
Adipose-Derived Stem Cells for Regenerative Medicine
Circ. Res., May 11, 2007; 100(9): 1249 - 1260.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2006